Purchases and Sales Made in Q4 2022 in Werewolf Therapeutics, Inc. (HOWL)
This table provides information about the institutional ownership of Werewolf Therapeutics, Inc. (HOWL) during Q4 2022. The information is specifically focused on institutions that hold shares of Werewolf Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
1.53M+ 43994.08% |
$2.34M - $7.24M
|
1.53M
$2.44M
|
|
|
Feb 10, 2023
Q4 2022
|
Rubric Capital Management LP
New York, NY |
BUY
|
- |
869K+ 89.83% |
$1.33M - $4.11M
|
1.84M
$2.92M
|
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
327K+ 63.86% |
$500K - $1.55M
|
838K
$1.33M
|
|
|
Feb 13, 2023
Q4 2022
|
Tejara Capital LTD
London, X0 |
BUY
|
- |
129KNew |
$197K - $609K
|
129K
$205K
|
|
|
Feb 14, 2023
Q4 2022
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
BUY
|
- |
101KNew |
$155K - $479K
|
101K
$161K
|
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
59.9K+ 327.45% |
$91.7K - $283K
|
78.2K
$124K
|
|
|
Feb 14, 2023
Q4 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
40K+ 95.9% |
$61.2K - $189K
|
81.7K
$130K
|
|
|
Feb 14, 2023
Q4 2022
|
Acadian Asset Management LLC
Boston, MA |
BUY
|
- |
29.5KNew |
$45.1K - $140K
|
29.5K
$46.9K
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
27.2KNew |
$41.6K - $129K
|
27.2K
$43.2K
|
|
|
Feb 14, 2023
Q4 2022
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
22.1KNew |
$33.8K - $104K
|
22.1K
$35.1K
|
|
|
Feb 14, 2023
Q4 2022
|
Prudential Financial Inc
Newark, NJ |
BUY
|
- |
21KNew |
$32.1K - $99.3K
|
21K
$33.4K
|
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
13.7K+ 3.14% |
$20.9K - $64.7K
|
449K
$714K
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
11KNew |
$16.9K - $52.2K
|
11K
$17.5K
|
|
|
Feb 09, 2023
Q4 2022
|
Chicago Partners Investment Group LLC
|
BUY
|
- |
10.7KNew |
$16.4K - $50.7K
|
10.7K
$17.1K
|
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
9.55K+ 7.94% |
$14.6K - $45.1K
|
130K
$206K
|
|
|
Feb 14, 2023
Q4 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
8.4K+ 34.19% |
$12.9K - $39.7K
|
33K
$52.4K
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
615+ 9.42% |
$941 - $2.91K
|
7.15K
$11.4K
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
6+ 6.82% |
$9.18 - $28.4
|
94
$149
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-114- 0.61% |
$174 - $539
|
18.4K
$29.3K
|
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-353- 82.67% |
$540 - $1.67K
|
74
$118
|
|
|
Feb 14, 2023
Q4 2022
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-385- 99.48% |
$589 - $1.82K
|
2
$3.18
|
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-752- 50.13% |
$1.15K - $3.56K
|
748
$1.19K
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-1K- 40.9% |
$1.53K - $4.74K
|
1.45K
$2.3K
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-7.98K- 76.05% |
$12.2K - $37.7K
|
2.51K
$3.99K
|
|
|
Feb 09, 2023
Q4 2022
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-9.79K- 37.66% |
$15K - $46.3K
|
16.2K
$25.8K
|
|
|
Feb 14, 2023
Q4 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-88.1K- 76.87% |
$135K - $417K
|
26.5K
$42.1K
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-109K- 73.96% |
$167K - $518K
|
38.5K
$61.3K
|
|
|
Feb 14, 2023
Q4 2022
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-1.52M- 54.07% |
$2.33M - $7.2M
|
1.29M
$2.06M
|